Navigation Links
Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
Date:2/19/2013

arily due to lower sales to large chains relative to the prior year quarter.

For the full year 2012, Anda Distribution segment net revenues increased 27 percent to $986.4 million, compared to $776.2 million in 2011. This increase was primarily due to new product launches.

Other Operating ExpensesConsolidated GAAP general and administrative expenses were $228.6 million in the fourth quarter 2012, an increase of $125.4 million from the fourth quarter 2011 due to the inclusion of legacy Actavis including certain acquisition, integration and restructuring charges. The current year period was also impacted by charges associated with a product liability settlement. 

Amortization expense for the fourth quarter 2012 was $148.2 million, compared to $151.3 million in fourth quarter 2011.

For the full year 2012, consolidated GAAP general and administrative expenses were $624.9 million, compared to $353.1 million in the prior year period, an increase of $271.8 million.  The increase was due to the acquisition of Ascent and the Actavis Group in January 2012 and November 2012, respectively, including costs associated with the acquisition and integration of these businesses.  Litigation settlements also contributed to the year over year increase.

Amortization expense for the full year 2012 was $481.1 million, compared to $354.3 million in full year 2011, primarily due to atorvastatin and levalbuterol product rights, and amortization of product rights and other intangible assets acquired in the Actavis Group, Specifar, and Ascent acquisitions.

2013 Financial Outlook Actavis' estimates are based on actual results for 2012 and management's current belief about prescription trends, pricing levels, inventory levels and the anticipated timing of future product launches and events. 

Actavis estimates total net revenue for 2013 of approximately $8.1 billion.

  • Total Actavis Pharma segment revenue of between
    '/>"/>

    • SOURCE Actavis, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Watson to Acquire Actavis Group for EUR4.25 Billion
    2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
    3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
    4. Watson and Actavis Receive FTC Second Request
    5. Watson Announces New Name -- Actavis -- for Global Operations
    6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
    7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
    8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
    9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
    10. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
    11. Aethlon Medical Note: Fiscal Year Revenue Guidance
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/17/2013)... 17, 2013   Shareholder rights attorneys  at Robbins ... Inc. (NASDAQGS: AVEO) securities has filed a complaint in ... Massachusetts .  The complaint alleges that Aveo ... Act of 1934 (the "Exchange Act") between January 3, ... (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ) ...
    (Date:5/17/2013)... , May 17, 2013 ... economics and outcomes research also   to   be ... SHPG ), the global specialty biopharmaceutical company, ... poster presentations at the American Psychiatric Association (APA) 166th ... May 18-22. The data being presented represent Shire,s ongoing ...
    (Date:5/17/2013)... Rico , May 17, 2013  Serving a region ... Puerto Rico , Caribbean Imaging and Radiation Therapy (CIRT, ... radiation therapy capabilities with the acquisition of an Elekta Versa ... . Versa HD offers clinicians the versatility to deliver conventional ... body, while also enabling treatment of highly complex cancers that ...
    Breaking Medicine Technology:Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2
    ... NOVATO, Calif., Dec. 14, 2010 BioMarin Pharmaceutical Inc. (Nasdaq: ... Healthcare Products Regulatory Agency (MHRA) in the UK has completed ... notice of acceptance for the Phase 3 trial of N-acetylgalactosamine ...  The company expects to initiate the Phase 3 pivotal trial ...
    ... Dec. 14, 2010 Pharmasset, Inc. (Nasdaq: VRUS ... study of PSI-7977, a nucleotide analog polymerase inhibitor, for the ... PSI-7977 400mg QD in combination with ribavirin (RBV), with 0, ... (Peg-IFN) in treatment-naive patients infected with HCV genotype 2 or ...
    Cached Medicine Technology:MHRA Issues Notice of Acceptance for Phase 3 Trial of GALNS for the Treatment of MPS IVA 2MHRA Issues Notice of Acceptance for Phase 3 Trial of GALNS for the Treatment of MPS IVA 3Pharmasset Initiates Exploratory Interferon Sparing Clinical Trial of PSI-7977 for Chronic Hepatitis C 2Pharmasset Initiates Exploratory Interferon Sparing Clinical Trial of PSI-7977 for Chronic Hepatitis C 3
    (Date:5/19/2013)... Omaha, Nebraska is a city of diversity, economic ... of the lowest unemployment rates in the country. Forbes Magazine ... for Business and Careers and it consistently scores high on ... located in the nation and is a strong business leader ... of Editions TV are pleased to announce air ...
    (Date:5/19/2013)... Chicago, IL (PRWEB) May 19, 2013 In ... Surge, LLC, E-dentist.com has announced the launch of an SEO ... help dentists get high rankings in Google. , http://www.e-dentists.com/ ... do not pay for the service until they see results. ... sites. The lead generation websites run by JD Media Surge, ...
    (Date:5/19/2013)... The muscles in the human body ... one of the biggest and most significant nervous systems ... peripheral system comprises of peripheral nerves that reside outside ... ensure that the limbs and hands, as well as ... get damaged due to trauma or physical injury, their ...
    (Date:5/19/2013)... California (PRWEB) May 19, 2013 Grinding ... than just losing sleep, or annoying your spouse. At ... report by CNY Central (“Snoring and Teeth Grinding Could ... type of teeth grinding can be hard to prevent. ... million Americans, and one of its symptoms is a ...
    (Date:5/19/2013)... 6Webs.com is the leader in reviews ... are considering an alarm system can do a comparison ... security system providers online at 6Webs.com. Just recently finishing ... home security system companies, 6Webs.com currently is announcing ... home security companies before ranking the home security system ...
    Breaking Medicine News(10 mins):Health News:Editions TV Announces May Air Dates for Omaha, Nebraska 2Health News:Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC 2Health News:Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Top Rated DIY Home Security System Companies Published by 6Webs.com 2
    ... possible relation between acne and milk. Dermatologists at ... culprit is Iodine. ,Teenagers being plagued with acne can ... out. Previously thought to be hormones or “bioactive chemicals” ... is credited with the finding. , ,"It has been ...
    ... auditory and visual aspects of speech can be processed much ... hearing impairment, if the cochlear implant is carried out at ... implants. About 36 profoundly deaf children aged between 5 years ... had received the cochlear implant for a period of one ...
    ... assess the effectiveness of the federal government’s plans to ... the United States, the White House is hosting a ... for four hours and would be attended by Cabinet ... President however would be excluded from the top-level meeting, ...
    ... In a new, unique study conducted on babies and birth ... birth weight display an increased liking for salt.// The results ... individuals include more salt in their diet than others. ... atleast 2.5 kg. These babies were given both plain and ...
    ... are obese before pregnancy or who smoke during pregnancy, have ... age//. ,The researchers also say the condition ... research paper published in the journal Pediatrics. ... Ohio State University, Columbus, who were interested in how pre-pregnancy ...
    ... study conducted and headed by Veronique Roger, M.D., M.P.H., at ... is a high risk of these patients suffering from stroke//. ... was 44 times more during the 30 day period after ... person. ,The study is very important because with today’s ...
    Cached Medicine News:Health News:Early Cochlear Implants Prove To Be Effective 2Health News:Birth Weight of Babies Important Predictor for Salt Preference 2Health News:Kids of overweight mothers have higher obesity risk 2
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: